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Portable Blood Gas and Electrolyte Analyzer
Evaluated in a Multiinstitutional Study
Jan Lindemans,1* Peter Hoefkens,1 Antonius L. van Kessel,2 Marc Bonnay,3
Wolf R. Ku¨lpmann,4 and Jeroen D.E. van Suijlen5
A recently introduced blood gas/electrolyte analyzer
(SenDx 100®, renamed ABL70) intended for point-of-
care, near-patient, or stat laboratory use was evaluated
simultaneously in four different institutions and com-
pared with three different laboratory bench analyzers
with respect to imprecision, inaccuracy (assessed by
tonometry), and patient-sample analyses. The analyzer
is equipped with a sensor cassette and a reagent car-
tridge for 50, 100, or 200 analyses and 100 or more
traditional quality-control measurements. One analysis
requires 170 mL of whole blood and takes <90 s.
Statistically, the instrument performed somewhat better
(lower CVs) for PO2 and potassium and somewhat worse
for pH, PCO2, and ionized calcium than the respective
comparison analyzers. However, the overall perfor-
mance (in terms of CV and accuracy) was satisfactory in
terms of clinical (e.g., CLIA ’88) goals in all institutions.
The mean difference and the CV of that difference in
some 400 patient-sample comparisons were as follows:
0.010 (6 0.002%) for pH, 20.65 mmHg (6 4%) for PCO2,
20.49 mmHg (6 6%) for Po2, 0.44 mmol/L (6 1.2%) for
sodium, 20.013 mmol/L (6 2.9%) for potassium, 20.016
mmol/L (6 2.6%) for ionized calcium, and 20.016 L/L (6
7.1%) for the hematocrit. Its acceptable analytical per-
formance and ease of operation make the SenDx 100
suitable for the analysis of blood gases and electrolytes.
Changes in the practice of clinical chemistry and clinical
medicine have paved the way for the introduction of
small- and medium-sized devices (1–5) for the measure-
ment of vital clinical chemistry indicators near the patient,
at the bedside or, as commonly called today, at the point
of care. This development has been fostered by advances
in sensor technology that have obviated the need for
preanalytical separation of blood cells and plasma. An
important advantage of these devices is the reduction of
preanalytical errors associated with centralized testing,
e.g., ongoing metabolism and electrolyte movements in
the blood cells during transport of the sample and gas
exchange through the (mostly plastic) wall of the syringe (6).
One of the latest newcomers in this field of decentral-
ized point-of-care testing by use of sensor technology is
the SenDx 100® blood gas/electrolyte analyzer (SenDx
Medical, Inc., Carlsbad, CA).6 This portable tabletop in-
strument contains a sample introduction stylus, a dispos-
able sensor cassette, a printer, a liquid crystal display
touch color screen, and a disposable calibration cartridge.
Each combination of calibration cartridge and sensor
cassette allows the measurement of 50, 100, or 200 patient
samples and at least 100 control samples within a period
of 2 weeks. The cartridge contains sensors for pH, Pco2,
Po2, sodium, potassium, ionized calcium, and conductiv-
ity (as a measure for hematocrit).
The SenDx 100 retains the features of a traditional
laboratory bench analyzer but is portable and is intended
for use in a near-patient setting. The SenDx 100 permits
traditional quality-control procedures, which cover the
entire analytical phase of the measurement, including the
sensors. Specific lock-out procedures in the resident soft-
ware preclude use of an improperly functioning sensor
cassette or use by unauthorized personnel.
In the present study, four instruments were evaluated
at four different clinical institutions with respect to im-
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precision, inaccuracy, and comparability of patient-sam-
ple results with three different routinely used laboratory
blood gas/electrolyte analyzers.
Materials and Methods
SenDx 100 portable blood gas/electrolyte
analysis system
Each of the participating hospital laboratories (identified
as A, B, C, and D) was equipped with a SenDx 100
analyzer and a sufficient number of two lots of calibration
cartridges and sensor cassettes to complete the study, all
made available by the manufacturer. The analyzers were
operated according to the manufacturer’s standard oper-
ating procedures and without special adjustments by the
manufacturer.
The analyzer measures 13 3 8 3 9 inches and weighs
14 pounds. The sensors are incorporated into a visible
sample measurement cassette that uses ;170 mL of blood
sample, which is introduced by aspiration. The tempera-
ture of the measuring chamber is monitored continuously
and regulated at 37.0 °C during calibration and analysis.
A self-contained disposable cartridge contains the calibra-
tor/wash reagents and a waste container. In this study,
the instrument was ready for analysis continuously and
did not need preanalysis calibration. An automatic two-
point calibration was scheduled every 4 h. The built-in
battery is charged continuously when the analyzer is
plugged into an electrical outlet, which allows the instru-
ment to operate on battery power for ;30 analyses or 1 h.
Patient data and quality-control results can be down-
loaded and stored on disk. The built-in printer provides a
hard copy of patient results and calibration and quality-
control data.
thin-film tonometer
Each testing site was equipped with an IL 237 tonometer
(Instrumentation Laboratory Co.) and supplied with ap-
propriate, certified gas mixtures.
comparison analyzers
Laboratories A and C used the ABL 505 from Radiometer;
laboratory B used Chiron 288 and 270 (Chiron Diagnos-
tics) as comparison instruments. Laboratory D used an
Instrumentation Laboratory type 1312 blood gas analyzer
for blood gases and the Beckman CX3 analyzer (Beckman
Instruments) for electrolytes (on plasma samples). Hemat-
ocrit comparisons were conducted against routinely used
automated hematology analyzers, which were themselves
calibrated against the centrifuged hematocrit.
materials
For imprecision studies, the “three-level” Euro-Trol Gas-
ISE Protein, lot nos. AD1–541C, AD2–543C, and AD3–
544C, respectively (Euro-Trol bv) were used in all partic-
ipating laboratories. Comparison instruments were used
with the manufacturers’ reagents and calibrators. For
tonometry, each laboratory applied two different gas
mixtures, which were analyzed with a relative inaccuracy
of ,2% for O2 and CO2 (in practice between 0.1 and 0.2
volume percent absolute) and certified.
whole blood samples
Each testing site analyzed 80–100 anaerobically handled,
heparin-treated (3-mL syringe with 7 units/mL dry lith-
ium heparin) patient samples, selected without conscious
bias from those received routinely in the laboratory. For
tonometry, heparin-treated (15 units/mL) whole blood
was collected from healthy human volunteers.
protocol
Within-day imprecision. On each of 3 days, sequential
samples of each Euro-Trol control were analyzed 10 times
with one cartridge on the SenDx 100 and the comparison
analyzer in each laboratory. This procedure was repeated
with another calibration cartridge and sensor cassette of a
different lot number. In the four institutions, three differ-
ent cartridge/cassette combinations in total were used.
Laboratory B accidentally omitted the comparison ana-
lyzer data from the within-day imprecision study; labo-
ratory D did not provide comparison analyzer data for
electrolyte because they could not use the control material
in their comparison analyzer.
Between-day imprecision. For 10 days, a Euro-Trol control
was analyzed in duplicate with both the SenDx 100 and
the comparison analyzer in random order.
Tonometry. Tonometry using fresh, heparin-treated hu-
man whole blood was performed, according to IFCC
recommendations on tonometry of blood (7), on 3 days on
both the SenDx 100 and the corresponding comparison
analyzer in each laboratory. For each gas mixture, the
exact partial pressures were calculated daily, with baro-
metric pressures taken into into consideration. The tem-
perature of the blood/gas equilibrium chamber was care-
fully monitored to maintain a constant tonometer
temperature of 37.0 6 0.1 °C. This procedure was re-
peated with a different cassette and calibration cartridge.
The differences of 10 consecutive measurements with
the corresponding target value were calculated and aver-
aged. The overall mean of all averaged differences was
then taken as a measure for inaccuracy, either absolute or
as a percentage of the target value.
Method comparison. Each participating laboratory analyzed
80–100 anaerobically handled blood samples in split-
sample fashion with the SenDx 100 analyzer and the corre-
sponding comparison instrument, according to NCCLS
guidelines (8).
Patient blood samples collected in heparin-containing
syringes were taken at random from those submitted
routinely to the laboratory by pneumatic tube or by hand
delivery. The samples were remixed by hand immediately
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and analyzed with the SenDx 100 and the comparison
analyzer. The maximum allowable time interval between
the two measurements was 3 min. In laboratory D,
one-half the sample was transferred to a centrifuge tube,
and plasma for electrolyte measurement on the CX3 was
prepared by centrifugation. The other half was used for
measuring blood gases on the SenDx 100 and the compar-
ison analyzer.
Two different SenDx 100 cassettes were used (40–50
samples/cassette), each for at least 5 days. On each
operating day, sampling of two Euro-Trol control materi-
als was scheduled to ascertain that both analyzers were
within 2 SD of the target value during the whole compar-
ison period.
statistical data analysis
Before statistical analysis, all data were subjected to an
outlier rejection procedure according to the NCCLS
EP9-A guideline (8). All data from different observation
days and different lot numbers were processed together
unless indicated. The significance of differences in the
means were tested using the Student t-test. Patient-sam-
ple comparisons were pooled from all four institutions
and analyzed by calculating the slope and intercept from
a regression analysis according to Passing and Bablok (9);
bias and variability of differences were analyzed accord-
ing to Bland and Altman (10).
Results
imprecision studies
During the whole study, all cassettes and cartridges
remained within the quality-control specifications up to
their indicated expiration dates.
Generally, the within-day imprecision of the four in-
struments and the respective comparison analyzers
showed similar CVs for pH, Po2, Pco2, and potassium
(Table 1). Sodium and ionized calcium measurements on
the SenDx 100 were less precise than those of the com-
parison analyzers. The between-day imprecision (Table 2)
was better on most comparison instruments for pH, Pco2,
sodium, and ionized calcium, but was better on the SenDx
100 for Po2 and potassium. There were no clinically
significant differences (generally ,2%) between different
sensor cassettes and reagent cartridges. Table 3 summa-
rizes the averaged data for all control materials in all four
centers. The CV data for within- and between-day impre-
cision for electrolytes in laboratory D were obtained
separately with a different sample type and given just for
the purpose of comparison with a different technique
(indirect measurement).
Table 1. Within-day imprecision.
CV, %a
Laboratory A Laboratory B Laboratory C Laboratory D
SenDx Comp.b SenDx Comp. SenDx Comp. SenDx Comp.
pH
7.179 0.004 0.003 0.003 ND 0.004 0.002 0.003 0.003
7.398 0.002 0.001 0.001 ND 0.007 0.003 0.005 0.003
7.572 0.003 0.003 0.001 ND 0.012 0.001 0.002 0.004
PCO2, mmHg
61.0 1.6 1.5 1.8 ND 2.2 1.0 1.3 1.6
38.5 1.7 1.0 1.0 ND 2.0 0.9 1.8 0.8
21.9 1.6 1.2 0.8 ND 3.7 0.8 2.0 1.1
PO2, mmHg
59.5 5.0 3.6 2.2 ND 2.5 5.2 3.2 7.1
99.8 4.2 2.3 1.4 ND 1.6 3.0 2.3 5.4
136.8 3.2 3.3 1.3 ND 1.4 1.6 2.2 4.8
Na1, mmol/L
121 0.6 0.4 0.3 ND 0.7 0.1 ND ND
139 0.5 0.2 0.2 ND 0.6 0.1 ND 0.4
160 0.9 0.3 0.3 ND 1.0 0.1 ND ND
K1, mmol/L
2.9 0.4 0.6 0.4 ND 0.6 0.2 ND ND
4.3 0.3 0.4 0.2 ND 0.6 0.1 ND 0.4
5.8 0.6 0.4 0.2 ND 0.6 0.1 ND ND
iCa21, mmol/L
1.70 1.6 0.7 1.2 ND 1.3 0.3 ND ND
1.18 1.4 0.5 0.5 ND 2.9 0.4 ND ND
0.60 2.6 1.3 1.0 ND 3.8 0.5 ND ND
a Imprecision for pH in SD.
b Comp., comparison method; ND, not determined; iCa21, ionized calcium.
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inaccuracy studies
The tonometry data for both Po2 and Pco2 are shown in
Table 4. The mean recoveries with the SenDx 100 at ;70
and 142 mmHg Po2 were 98.5% and 95.2%, respectively;
at ;36 and 72 mmHg Pco2, the mean recoveries were
103.9% and 100.2%, respectively. The data on the compar-
ison analyzers were somewhat more favorable. The data
from one center were also used to evaluate the within-run
and between-run imprecision with heparin-treated non-
diseased human blood under controlled conditions. Table
5 shows that the imprecision values for Pco2 in the treated
whole blood were similar to the values for the Euro-Trol
control materials; however, the imprecision values for Po2
were much improved, as is expected when whole blood is
used instead of an aqueous solution.
method comparison
The results of the comparison of the SenDx 100 with the
comparison analyzers, using fresh patient samples are
represented in Fig. 1 and Table 6 for all analytes assayed.
The data from the four institutions are presented in one
graph, with a different symbol for each participant. This
makes it possible to discern general discrepancies caused
by bias in one specific laboratory.
Table 2. Between-day imprecision.
CV, %a
Laboratory A Laboratory B Laboratory C Laboratory D
SenDx Comp.b SenDx Comp. SenDx Comp. SenDx Comp.
pH
7.179 0.016 0.004 0.012 0.008 0.014 0.005 0.006 0.007
7.398 0.006 0.002 0.005 0.010 0.011 0.004 0.016 0.004
7.572 0.005 0.004 0.009 0.012 0.013 0.003 0.008 0.005
PCO2, mmHg
61.0 2.2 1.7 4.2 2.4 3.9 1.7 2.5 2.7
38.5 2.0 0.8 3.0 1.3 2.9 0.9 4.6 1.1
21.9 4.4 1.1 3.6 1.6 1.9 0.9 2.2 1.4
PO2, mmHg
59.5 3.7 6.8 7.6 10 14 13 4.5 8.5
99.8 2.9 3.8 9.5 7.0 4.1 6.0 4.3 4.2
136.8 2.9 4.2 5.1 4.8 4.4 4.1 5.0 7.3
Na1, mmol/L
121 1.4 0.7 0.8 1.2 0.8 0.2 ND ND
139 0.9 0.5 0.5 1.0 0.1 0.2 ND 0.8
160 1.1 0.5 0.8 1.4 1.9 0.3 ND ND
K1, mmol/L
2.9 0.9 2.3 0.6 1.3 0.2 0.4 ND ND
4.3 0.9 1.4 0.4 1.7 0.2 0.3 ND 0.9
5.8 0.8 0.8 0.3 2.0 0.5 0.4 ND ND
iCa21, mmol/L
1.70 3.5 0.4 3.7 9.5 2.7 0.8 ND ND
1.18 2.6 0.7 11 13 1.4 0.8 ND ND
0.60 7.1 5.7 6.5 26 3.4 1.3 ND ND
a Imprecision for pH in SD.
b Comp., comparison method; ND, not determined; iCa21, ionized calcium.
Table 3. Mean within- and between-day imprecision for all analyzers.
Within-day Between-day
SenDx 100 Comparison SenDx 100 Comparison
pH, SD 6 SD9 0.004 6 0.003 0.0025 6 0.0010 0.010 6 0.004 0.006 6 0.003
PCO2, CV 6 SD, % 2.8 6 0.7 1.1 6 0.3 3.1 6 1.0 1.4 6 0.7
PO2, CV 6 SD, % 2.8 6 1.2 4.0 6 1.7 5.7 6 3.2 6.7 6 2.8
Na1, CV 6 SD, % 0.7 6 0.2 0.2 6 0.1 0.9 6 0.5 0.7 6 0.4
K1, CV 6 SD, % 0.5 6 0.1 0.3 6 0.2 0.5 6 0.3 1.2 6 0.7
iCa21,a CV 6 SD, % 2.3 6 1.0 0.6 6 0.4 4.7 6 3.1 6.6 6 8.8b
a Ionized calcium.
b One comparison analyzer showed an unexplained high CV in this experiment.
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Fig. 1. Difference plots for the blood gases, electrolytes, pH, and
hematocrit (Hct) on the basis of 100 fresh patient samples per
institute.
The reference analyzer results minus the SenDx 100 results are on the y axes;
the mean results are on the x axes. :, laboratory A; , laboratory B; F, laboratory
C; f, laboratory D; the thick solid line is the zero difference line; (– – – –), mean
bias; ( z z z z z ), SE bias; (- - - - - -), 2 SD of difference. Blood gas values are in
mmHg, electrolytes are in mmol/L, and hematocrit is in L/L.
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For the pH, an average bias of only 0.010 was found,
with an insignificant positive trend (slope 5 0.984). The
Pco2 showed a bias of 20.65 mmHg, which was indepen-
dent of the partial pressure of CO2. The Po2 had a very
small positive slope (0.943), suggesting a slight depen-
dence on the partial pressure of O2. Otherwise there was
no significant difference from zero for the average bias of
20.49 mmHg.
With respect to sodium, a statistically significant but
otherwise small bias of 0.44 mmol/L was found in the
sample comparison study; there was no significant con-
centration dependency. The comparison for potassium
Table 4. PCO2 and PO2 in samples analyzed using tonometry.
Laboratory Target, mmHg
SenDx 100 Comparison analyzer
Found,a mmHg
Difference
Found,a mmHg
Difference
mmHg % mmHg %
PCO2
A 35.9 36.7 0.8 2.2 35.4 20.5 21.4
13.9 14.5 0.6 4.3 14.5 0.6 4.3
B 35.1 38.5 3.4 9.6 36.2 1.1 3.1
71.7 72.8 1.1 1.5 71.2 20.5 20.7
C 36.0 37.2 1.2 3.3 36.3 0.4 1.1
71.7 70.9 20.8 21.1 71.7 0.0 0.0
D 35.9 36.2 0.3 0.8 34.5 21.3 23.6
73.7 74.1 0.3 0.5 70.5 23.3 24.5
PO2
A 142 137.5 24.5 23.3 142.4 0.4 0.03
50 50 0.0 0.0 50.5 0.5 1.0
B 141 136.5 24.6 23.3 140.0 21.0 20.7
70.3 67.8 22.5 23.5 69.5 20.8 21.1
C 144 133.6 210.5 27.3 144.2 0.1 0.1
72.1 70.2 22.9 24.0 72.5 0.5 0.7
D 142 134.3 27.7 25.4 139.9 22.2 21.5
85.1 87.4 1.4 1.6 83.5 22.6 23.1
a All data presented are the means of 10 consecutive measurements.
Table 5. PCO2 and PO2 in samples analyzed using tonometry in a single institute.
a
Target, mmHg
SenDx 100 Comparison analyzer
Found/expected, % Mean SD, mmHg Mean CV, % Found/expected, % Mean SD, % Mean CV, %
PCO2
35.94 102.3 0.65 1.8 99.1 0.54 1.5
13.91 104.3 0.36 2.6 104.3 0.15 1.1
PO2
142.2 96.7 0.14 1.0 100.0 1.85 1.3
50.08 100.7 1.10 2.2 101.7 0.95 1.9
a Data are the mean results of blood samples after tonometry from six analyses on different days with different cartridges of two different lot numbers within one
laboratory.
Table 6. Patient-sample comparison.
Analyte Unit n Slope Intercept Sylx r
Average
difference
SD of
difference
SE
difference
pH 352 0.984 0.109 0.027 0.984 0.010 0.017 0.00091
PCO2 mmHg 349 1.002 20.459 1.763 0.964 20.65 1.66 0.089
PO2 mmHg 354 0.943 6.472 5.600 0.985 20.49 5.95 0.32
Na1 mmol/L 390 1.058 28.181 2.208 0.914 0.44 1.73 0.09
K1 mmol/L 397 1.038 20.135 0.138 0.968 20.013 0.118 0.006
iCa21a mmol/L 302 1.068 20.095 0.073 0.933 0.015 0.045 0.0026
Hct L/L 211 1.223 20.0535 2.156 0.904 20.016 0.032 0.0022
a iCa21, ionized calcium; Hct, hematocrit.
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showed no significant bias for all participants taken
together; however, a discrepancy was found for the
comparison analyzer in one laboratory (D), which gave
consistently higher results than the SenDx 100 analyzer.
Without these data, a small negative bias probably would
have occurred. Again, there was no apparent concentra-
tion dependency of the bias. The majority of ionized
calcium values were within close limits; therefore, it is
difficult to confirm or deny whether the differences between
analyzers were concentration-dependent. The average bias
is small, 0.015 mmol/L, but statistically significant.
The hematocrit showed a slightly negative slope and
an average bias of 20.016 L/L, with an SD of 0.032 L/L.
Discussion
The analytical performance of the SenDx 100 blood gas/
electrolyte analyzer was found to be comparable with that
of the various established laboratory bench analyzers. The
within-day imprecision for pH, Pco2, sodium, and ion-
ized calcium was slightly worse in the SenDx 100; the
within- and between-day imprecision for Po2 and potas-
sium was generally better in the SenDx 100. The differ-
ences were small and without much clinical significance
when compared with the analytical performance indica-
tors based on biological variation (11) or with the CLIA’88
performance rules (12). Importantly, any contributions of
different reagent cartridge and sensor cassette lot num-
bers to the overall imprecision are included in the data.
This is also applicable to the accuracy measurements.
Although the SenDx 100 analyzer demonstrated a larger
bias than the respective comparison analyzers, in partic-
ular for the Po2, the overall accuracies for Po2 and Pco2
were quite satisfactory in comparison with established
performance indicators for these analytes.
Different sensor systems react differently toward var-
ious matrices of quality-control materials. Differences in
performance between instruments can therefore be
judged best from split patient-sample comparisons. With
respect to differences between cartridge lots, no signifi-
cant differences were found for any of the investigated
analytes with the exception of ionized calcium, for which
the difference in bias between cartridges reached a signif-
icant value of 0.05 mmol/L (n 5 44). Clinically, this is of
little importance. For Po2, the average biases found at 70
and 140 mmHg were of the same magnitude as with the
tonometry experiment. The average SD of the individual
differences appears rather large (almost 6 mmHg). This
implies a CV of ;6% around the average Po2. This is in
fact not much larger than the CV of 4.2% for Pco2 in
the same experiment. Nevertheless, individual differ-
ences of 625 mmHg are disturbing. The majority of
these differences are, however, from one laboratory and
therefore cannot be attributed solely to the SenDx
analyzer.
In comparison with other point-of-care blood gas/elec-
trolyte analyzers, the SenDx 100 performs equally well (13).
The SenDx 100 provides a hematocrit value on the basis of
conductivity measurement. Stott et al. (14) have demon-
strated that such hematocrit determinations are relatively
insensitive to changes in the electrolyte composition of the
plasma in comparison with electronic particle-counting de-
vices, which use sample dilution in isotonic saline; however,
they are particularly sensitive to changes in plasma protein
composition in contrast hematocrits obtained with electronic
particle counting or centrifugation.
In conclusion, the SenDx 100 analyzer fulfills most of the
requirements for a portable blood gas/electrolyte analyzer:
acceptable precision and accuracy, comparability with labo-
ratory bench analyzers, ease of use, and fast results.
A. van Kessel served as a scientific adviser to SenDx
Medical Inc. until May 1, 1998.
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